Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Clinical trial NCT02191761 · COMPLETED
Trial details
- NCT number
- NCT02191761
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-19
- Primary completion
- 2015-05-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.